Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced- calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available […] The post FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions appeared first on Web-Release.

    The American University of Beirut Press (AUB Press) announced a new international distribution partnership with Inlibra, a Germany-based digital platform operated by NOMOS. Through this collaboration, AUB Press publications will now be hosted and distributed on Inlibra’s platform, significantly expanding their accessibility to scholars, students, and institutions worldwide. This partnership marks an important step in […] The post AUB Press Partners with Inlibra Digital Platform to Expand Global Reach appeared first on Web-Release.